Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. Actual GLP-1 acquisition creative; peptide/sermorelin keyword searches showed no matches. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A long care page develops a direct offer through product quality, treatment comparisons, care steps, customer stories and assessment entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The grid is a smart way to prove a flat price. Instead of saying the price won't go up, it shows a calendar of tiles with the same number in every one, which the viewer understands in a glance (it's the benefit turned into a picture). The headline names the medication and the price, so there's no guessing what the $129 buys, and the checkmarks below cover cancel anytime and no long-term commitment. Eden ran several versions of this creative from September 4, 2026.
The creative says $129 and the ad headline and copy say $99, so the first number under the image contradicts the one inside it. A shopper who reads both will wonder which applies, and price clarity is the entire point of the ad. Match the headline to the medication on the card ($129 tirzepatide here), or add semaglutide at $99 as a second row. A line on what keeps the price fixed (the page calls it a lifetime price guarantee) would also make all year long more believable.
It names the medication, the price and the promise in one line.
Repeating the same number across the year shows the flat price instead of claiming it.
The checkmarks cover commitment and cancellation, though the headline introduces a second price.
$129 a month for tirzepatide on the creative, framed as fixed all year; the ad headline and copy say $99 a dose.
The ad lands on Eden's GLP-1 affiliate page, a focused landing page whose hero shows both prices, $99/mo semaglutide and $129/mo tirzepatide, under monthly pricing at every dose. That resolves the mismatch quickly for anyone who clicks, and the ticker's lifetime price guarantee backs the all-year promise in the grid. The free assessment is the single next step, and the plan inclusions section further down explains what the monthly price covers.
Eden's GLP-1 affiliate page is a long, focused landing page that opens on semaglutide at $99/mo and tirzepatide at $129/mo with a free assessment, then covers quality, treatment, care steps, stories and FAQs. All 16 Eden ads in the Fluid library link here, mostly price comparisons plus creator and doctor videos.
The headline, three benefits, both monthly prices and the free assessment button answer what it costs and how to start, with Trustpilot and member-count proof alongside.
It covers where the medication comes from and who oversees care, answering whether a low price means cutting corners.
It explains the problem and how the treatment is meant to work, answering why someone would consider it at all.
It compares treatment options so the visitor can work out which one fits before starting the assessment.
It walks through the steps from assessment to ongoing care, answering what happens after the click.
It shows stories from customers, answering whether people like the visitor have used the service.
It lists what the plan includes and repeats the assessment entry, answering what the monthly price covers right before asking again.
It handles remaining questions and the safety and compounding disclosures, answering the last objections before signing up.
Read the full breakdown of this page
One of 16 Eden ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.